Fursultiamine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Fursultiamine
Skeletal formula of fursultiamine
Ball-and-stick model of the fursultiamine molecule
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral
ATC code
  • None
Legal status
Legal status
Identifiers
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
ECHA InfoCard 100.011.234
Chemical and physical data
Formula C17H26N4O3S2
Molar mass 398.54 g/mol
3D model (JSmol)

Fursultiamine (INN; Adventan, Alinamin-F, Benlipoid, Bevitol Lipophil, Judolor, Lipothiamine), chemically thiamine tetrahydrofurfuryl disulfide (TTFD), is a disulfide derivative of thiamine, or an allithiamine.[1] It was synthesized in Japan in the 1960s for the purpose of developing forms of thiamine with improved lipophilicity for treating vitamin B1 deficiency (i.e., beriberi),[1][2] and was subsequently commercialized not only in Japan but also in Spain, Austria, Germany, and the United States.[3] As a vitamin, it is available over-the-counter as well.[4]

In addition to its clinical indication of avitaminosis, fursultiamine has been studied in clinical trials for Alzheimer's disease[5] and autistic spectrum disorders[6] with promising but modest benefits. It has also been investigated in improving energy metabolism during exercise and reducing exercise-induced fatigue with conflicting results.[4][7][8][9]

Available Brands: Privitamix softgel (India)

See also[edit]

References[edit]

  1. ^ a b Lonsdale D (September 2004). "Thiamine tetrahydrofurfuryl disulfide: a little known therapeutic agent". Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 10 (9): RA199–203. PMID 15328496. 
  2. ^ Miura S (July 1965). "[The uptake and the distribution of thiamine propyl disulfide-35S by the rabbit's eye tissue]". Nippon Ganka Gakkai Zasshi (in Japanese). 69 (7): 792–807, discussion 807–8. PMID 5006719. 
  3. ^ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. p. 1932. ISBN 3-88763-075-0. 
  4. ^ a b Nozaki S, Mizuma H, Tanaka M, et al. (December 2009). "Thiamine tetrahydrofurfuryl disulfide improves energy metabolism and physical performance during physical-fatigue loading in rats". Nutrition Research (New York, N.Y.). 29 (12): 867–72. doi:10.1016/j.nutres.2009.10.007. PMID 19963160. 
  5. ^ Mimori Y, Katsuoka H, Nakamura S (March 1996). "Thiamine therapy in Alzheimer's disease". Metabolic Brain Disease. 11 (1): 89–94. doi:10.1007/BF02080934. PMID 8815393. 
  6. ^ Lonsdale D, Shamberger RJ, Audhya T (August 2002). "Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study". Neuro Endocrinology Letters. 23 (4): 303–8. PMID 12195231. 
  7. ^ Suzuki M, Itokawa Y (March 1996). "Effects of thiamine supplementation on exercise-induced fatigue". Metabolic Brain Disease. 11 (1): 95–106. doi:10.1007/bf02080935. PMID 8815395. 
  8. ^ Webster MJ, Scheett TP, Doyle MR, Branz M (1997). "The effect of a thiamin derivative on exercise performance". European Journal of Applied Physiology and Occupational Physiology. 75 (6): 520–4. doi:10.1007/s004210050198. PMID 9202948. 
  9. ^ Masuda H, Matsumae H, Masuda T, Hatta H (2010). "A thiamin derivative inhibits oxidation of exogenous glucose at rest, but not during exercise". Journal of Nutritional Science and Vitaminology. 56 (1): 9–12. doi:10.3177/jnsv.56.9. PMID 20354340. 

Further reading[edit]